Newsroom

PARIS--(BUSINESS WIRE)--SLB (NYSE: SLB) gab heute die Ergebnisse für das zweite Quartal 2025 bekannt. Ergebnisse des zweiten Quartals (in Millionen, außer Beträge pro Aktie) Drei Monate bis Veränderung 30. Juni2025 31. März2025 30. Juni2024 Sequenziell Im Vergleich zum Vorjahr Umsatz $8,546 $8,490 $9,139 1% -6% Ergebnis vor Steuern – GAAP-Basis $1,285 $1,063 $1,421 21% -10% Gewinn vor Steuern – GAAP-Basis 15.0% 12.5% 15.5% 251 Basisp. -52 Basisp. SLB zurechenbarer Nettogewinn - GAAP-Basis $1,01...

LOS ANGELES--(BUSINESS WIRE)--EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm...

LOS ANGELES--(BUSINESS WIRE)--ALT Investors Have Opportunity to Join Altimmune, Inc. Fraud Investigation with the Schall Law Firm...

LOS ANGELES--(BUSINESS WIRE)--UNCY Investors Have Opportunity to Join Unicycive Therapeutics, Inc. Fraud Investigation with the Schall Law Firm...

LOS ANGELES--(BUSINESS WIRE)--WPP Investors Have Opportunity to Join WPP plc Fraud Investigation with the Schall Law Firm...

ATLANTA--(BUSINESS WIRE)--The Coca-Cola Company heeft vandaag bekendgemaakt dat Luisa Ortega per 1 september president van de Europese branche wordt. Zij volgt Nikos Koumettis op, die na een carrière van 25 jaar bij het bedrijf in 2026 met pensioen gaat. Koumettis blijft tot 28 februari 2026 bij het bedrijf als senior adviseur. Hij zal ook zitting nemen in de raad van bestuur van Hindustan Coca-Cola Beverages Pvt. Ltd., een bottelaar in India die eigendom is van het bedrijf. Ortega kwam in 2019...

ATLANTA--(BUSINESS WIRE)--Georgia’s Path2College 529 Plan announced today that a Mableton, GA baby, Sinclair Lewis, has won the 2024 Path2College Newborn Sweepstakes....

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the following statement: Shortly after 2:30 p.m. ET today, Sarepta received an informal request from the U.S. Food and Drug Administration (FDA) to voluntarily halt shipment of ELEVIDYS (delandistrogene moxeparvovec), our gene therapy for Duchenne muscular dystrophy (Duchenne), in the U.S. We first heard of this potential request earlier in the da...

PORTLAND, Ore.--(BUSINESS WIRE)--In the ninth jury trial for wildfire survivors against PacifiCorp following the 2020 Labor Day Fires, a jury has awarded eleven plaintiffs a total of $56.1 million. This verdict follows a landmark class action verdict in 2023 that held PacifiCorp liable to the entire class of wildfire survivors who suffered losses. The sole question in the trials that have followed is survivors’ damages. The damages trials will continue for the remainder of 2025 and likely 2026....

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--The law firm of Kahn Swick & Foti, LLC (“KSF”) has commenced an investigation into Century Aluminum Company (NasdaqGS: CENX) (“Century”). KSF is investigating whether Century’s officers and/or directors breached their fiduciary duties or otherwise violated state or federal laws. If you hold shares of Century Aluminum Company (NasdaqGS: CENX), we urge you to contact KSF to discuss your legal rights, without obligation or cost to you, by calling KSF to...